small molecule

GLUCOPHAGE

METFORMIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyEMD Serono →See this company's full patent-cliff portfolio

Drug detail

Brand name	GLUCOPHAGE
Active ingredient	METFORMIN HYDROCHLORIDE
Strength	850MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	March 1995
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.